Comparison of responses to vasoactive drugs in human and rat cerebral arteries using myography and pressurized cerebral artery method

Cephalalgia

Volumn 33, Issue 3, 2013, Pages 152-159

  Grände, Gustaf ^a   Nilsson, Elisabeth ^a   Edvinsson, Lars ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

cerebral artery; human; Migraine; rat; vasodilator responses

Indexed keywords

ALPHA CALCITONIN GENE RELATED PEPTIDE; CARBACHOL; HISTAMINE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE 27; NITROPRUSSIDE SODIUM; PLACEBO; PROSTACYCLIN; PROSTAGLANDIN E2; SILDENAFIL; VASOACTIVE AGENT; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL TISSUE; ARTERIAL PRESSURE; ARTERY CONSTRICTION; ARTERY DILATATION; ARTICLE; BLOOD VESSEL REACTIVITY; BRAIN ANGIOGRAPHY; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MALE; MIDDLE CEREBRAL ARTERY; MIGRAINE; MYOGRAPHY; NONHUMAN; RAT; SPECIES DIFFERENCE;

ANIMALS; ARTERIAL PRESSURE; BLOOD FLOW VELOCITY; BLOOD-BRAIN BARRIER; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MALE; MIDDLE CEREBRAL ARTERY; MYOGRAPHY; RATS; RATS, SPRAGUE-DAWLEY; SPECIES SPECIFICITY; VASCULAR RESISTANCE; VASODILATOR AGENTS;

EID: 84872362723     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1177/0333102412468340     Document Type: Article

References (29)

1. Le H, Tfelt-Hansen P, Skytthe A, et al. Association between migraine, lifestyle and socioeconomic factors: A population-based cross-sectional study. J Headache Pain. 2011 ; 12: 157-172
2. Messlinger K. Migraine: Where and how does the pain originate?. Exp Brain Res. 2009 ; 196: 179-193
3. Akerman S, Holland PR, Goadsby PJ. Diencephalic and brainstem mechanisms in migraine. Nat Rev Neurosci. 2011 ; 12: 570-584
4. Olesen J, Burstein R, Ashina M, et al. Origin of pain in migraine: Evidence for peripheral sensitisation. Lancet Neurol. 2009 ; 8: 679-690
5. Edvinsson L, Goadsby PJ. Extracerebral manifestations in migraine.. A peptidergic involvement?. J Intern Med. 1990 ; 228: 299-304
6. Edvinsson L, Linde M. New drugs in migraine treatment and prophylaxis: Telcagepant and topiramate. Lancet. 2010 ; 376: 645-655
7. Bryan RM, Jr, Eichler MY, Swafford MW, et al. Stimulation of alpha 2 adrenoceptors dilates the rat middle cerebral artery. Anesthesiology. 1996 ; 85: 82-90
8. Mulvany MJ, Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res. 1977 ; 41: 19-26
9. Wienecke T, Olesen J, Oturai PS, et al. Prostaglandin E2 (PGE2) induces headache in healthy subjects. Cephalalgia. 2009 ; 29: 509-519
10. Chan KY, Baun M, de Vries R, et al. Pharmacological characterization of VIP and PACAP receptors in the human meningeal and coronary artery. Cephalalgia. 2011 ; 31: 181-189
11. Kruuse C, Thomsen LL, Birk S, et al. Migraine can be induced by sildenafil without changes in middle cerebral artery diameter. Brain. 2003 ; 126: 241-247
12. Kruuse C, Khurana TS, Rybalkin SD, et al. Phosphodiesterase 5 and effects of sildenafil on cerebral arteries of man and guinea pig. Eur J Pharmacol. 2005 ; 521: 105-114
13. Uski T, Andersson KE, Brandt L, et al. Responses of isolated feline and human cerebral arteries to prostacyclin and some of its metabolites. J Cereb Blood Flow Metab. 1983 ; 3: 238-245
14. Myren M, Olesen J, Gupta S. Pharmacological and expression profile of the prostaglandin I-2 receptor in the rat craniovascular system. Vasc Pharmacol. 2011 ; 55: 50-58
15. Myren M, Baun M, Ploug KB, et al. Functional and molecular characterization of prostaglandin E2 dilatory receptors in the rat craniovascular system in relevance to migraine. Cephalalgia. 2010 ; 30: 1110-1122
16. Kellogg DL, Zhao JL, Coey U, et al. Acetylcholine-induced vasodilation is mediated by nitric oxide and prostaglandins in human skin. J Appl Physiol. 2005 ; 98: 629-632
17. Schytz HW, Wienecke T, Olesen J, et al. Carbachol induces headache, but not migraine-like attacks, in patients with migraine without aura. Cephalalgia. 2010 ; 30: 337-345
18. Van der Schueren BJ, Lunnon MW, Laurijssens BE, et al. Does the unfavorable pharmacokinetic and pharmacodynamic profile of the iNOS inhibitor GW273629 lead to inefficacy in acute migraine?. J Clin Pharmacol. 2009 ; 49: 281-290
19. Olesen J, Iversen HK, Thomsen LL. Nitric-oxide supersensitivity - a possible molecular mechanism of migraine pain. Neuroreport. 1993 ; 4: 1027-1030
20. Lassen LH, Christiansen I, Iversen HK, et al. The effect of nitric oxide synthase inhibition on histamine induced headache and arterial dilatation in migraineurs. Cephalalgia. 2003 ; 23: 877-886
21. Wienecke T, Olesen J, Ashina M. Prostaglandin I2 (epoprostenol) triggers migraine-like attacks in migraineurs. Cephalalgia. 2010 ; 30: 179-190
22. Hansen JM, Hauge AW, Olesen J, et al. Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura. Cephalalgia. 2010 ; 30: 1179-1186
23. Rahmann A, Wienecke T, Hansen JM, et al. Vasoactive intestinal peptide causes marked cephalic vasodilation, but does not induce migraine. Cephalalgia. 2008 ; 28: 226-236
24. Schytz HW, Birk S, Wienecke T, et al. PACAP38 induces migraine-like attacks in patients with migraine without aura. Brain. 2009 ; 132: 16-25
25. Ottosson A, Jansen I, Edvinsson L. Characterization of histamine receptors in isolated human cerebral arteries. Brit J Pharmacol. 1988 ; 94: 901-907
26. Jansen-Olesen I, Jorgensen L, Engel U, et al. In-depth characterization of CGRP receptors in human intracranial arteries. Eur J Pharmacol. 2003 ; 481: 207-216
27. Edvinsson L, Ekman R. Distribution and dilatory effect of vasoactive intestinal polypeptide (VIP) in human cerebral arteries. Peptides. 1984 ; 5: 329-331
28. Jansen-Olesen I, Gulbenkian S, Engel U, et al. Peptidergic and non-peptidergic innervation and vasomotor responses of human lenticulostriate and posterior cerebral arteries. Peptides. 2004 ; 25: 2105-2114
29. Antonova M, Wienecke T, Olesen J, et al. Prostaglandin E2 induces immediate migraine-like attack in migraine patients without aura. Cephalalgia. 2012 ; 32: 822-833